Genworth Financial, Inc. (GNW) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presented a mixed picture: strong share repurchase activity and solid Enact performance are positives, but future premium approvals and Closed Block losses present risks. The Q&A highlighted management's confidence in RBC ratio management and strategic plans to counteract pressures. However, the lack of explicit reasons for financial changes and the uncertainty around future premium approvals and Closed Block sustainability temper overall sentiment. Given the company's market cap and mixed signals, a neutral stock price movement is expected.
Key Financial Performance
Net Income $47 million, with adjusted operating income excluding the Closed Block of $109 million. The reasons for the change were not explicitly mentioned.
Enact Adjusted Operating Income $140 million. This was driven by strong performance, including a pretax reserve release of $39 million due to continued strong cure performance. Results were up year-over-year due to increased investment income and favorable expenses.
Holding Company Liquidity $166 million in cash and liquid assets. No specific year-over-year change or reasons for change were mentioned.
Capital Returns from Enact $99 million in total capital returns in the first quarter. No specific year-over-year change or reasons for change were mentioned.
Share Repurchase Program $875 million worth of shares repurchased at an average price of $6.38 as of April 30. No specific year-over-year change or reasons for change were mentioned.
CareScout Service Revenue $6 million in revenue in the first quarter, with a target of $25 million for the full year 2026. No specific year-over-year change or reasons for change were mentioned.
Closed Block Adjusted Operating Loss $32 million, driven by a liability remeasurement loss related to actual variances from expected experience (A/E) of $36 million pretax, primarily in LTC. Results were favorably impacted by net insurance recoveries of $65 million pretax.
New Insurance Written by Enact $13 billion in the quarter, increased year-over-year due to lower interest rates early in the quarter.
Primary Insurance In-Force by Enact $272 billion, increased year-over-year due to growth in new insurance written and continued elevated persistency.
Enact Earned Premiums $243 million, down slightly year-over-year. No specific reasons for the change were mentioned.
Enact Pretax Reserve Release $39 million, reflective of continued strong cure performance. This contributed to a loss ratio of 15%.
Enact PMIERs Sufficiency Ratio 162%, or approximately $1.9 billion above requirements. No specific year-over-year change or reasons for change were mentioned.
Closed Block Premium Approvals $5 million of gross incremental premium approvals in the first quarter, with an additional $45 million achieved in the second quarter. No specific year-over-year change or reasons for change were mentioned.
Closed Block Economic Value from MYRAP Approximately $34.5 billion in net present value since 2012, with $1 billion expected in 2026. No specific year-over-year change or reasons for change were mentioned.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
CareScout Aging Platform: Expanded the CareScout Quality Network (CQN) to include senior living communities, aiming for 1,000 home care locations and 2,000 senior living communities by the end of 2026. Facilitated 1,500 matches in Q1 2026, targeting 7,500 matches by year-end 2026. Revenue model includes one-time placement fees for senior living communities.
Care Assurance Product: Introduced a differentiated LTC insurance product integrating CareScout services. Plans to launch a worksite product later in 2026 and develop hybrid LTC insurance products.
Enact Market Position: Generated $140 million in adjusted operating income in Q1 2026. Maintains an 81% ownership stake, contributing $99 million in capital returns in Q1. Positioned for strong free cash flow and disciplined underwriting.
Closed Block Management: Achieved $5 million in premium approvals in Q1 2026, with an additional $45 million in Q2. Cumulatively achieved $34.5 billion in net present value through premium increases and benefit reductions since 2012.
AI and Technology Integration: Implemented AI initiatives to improve claim management, customer service, and scalability across CareScout.
Capital Allocation: Repurchased $66 million in shares in Q1 2026, with an additional $19 million through April 30. Retired $5 million in debt, maintaining a disciplined capital structure.
Litigation Recovery: Potential recovery of $750 million from AXA litigation, with proceeds to be allocated to CareScout, shareholder returns, and debt reduction.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Macroeconomic Uncertainty: The company is closely monitoring an uncertain and dynamic external environment, including uneven consumer spending and the potential for higher inflation and interest rates, which could impact financial performance.
Closed Block Sustainability: The Closed Block segment reported an adjusted operating loss of $32 million, driven by liability remeasurement losses and other factors. The company expects approximately $300 million in A/E losses for the full year 2026, highlighting ongoing challenges in managing long-term care (LTC) insurance policies.
Regulatory and Legal Risks: The company is involved in litigation with AXA, with an appeal hearing scheduled. The outcome remains uncertain, and any potential recoveries are not factored into capital allocation plans.
CareScout Scaling Challenges: The company is investing heavily in scaling CareScout, with $50-$55 million planned for 2026. Achieving breakeven and long-term scalability will take time, and there are risks associated with building out technology platforms, expanding product offerings, and growing distribution networks.
Investment Portfolio Risks: The investment portfolio is exposed to market fluctuations, including geopolitical tensions and interest rate changes, which could impact returns and financial stability.
Premium Rate Action Plan: The Multi-Year Rate Action Plan (MYRAP) is in its later stages, with future premium approvals expected to be lower. This could impact the company's ability to maintain the sustainability of its Closed Block.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
CareScout Revenue and Growth: CareScout Services is expected to generate $25 million in revenue for 2026, with a target of approximately 7,500 matches across home care providers and senior living communities. Investments of $50 million to $55 million are planned to scale the business, expand its reach, and enhance operational infrastructure.
Enact Capital Returns: Enact is expected to return approximately $405 million to Genworth in 2026, based on its 81% ownership position. Enact has increased its quarterly dividend and continues to operate with strong financial performance.
Share Repurchase Program: Genworth plans to allocate between $195 million and $225 million to share repurchases in 2026, depending on market conditions, business performance, and share price.
Closed Block Premium Approvals: Full-year 2026 premium approvals and benefit reductions are expected to be broadly in line with 2025 levels, contributing approximately $1 billion of economic value on a net present value basis.
CareScout Insurance Product Launch: The Care Assurance worksite product is planned for launch later in 2026, broadening access through employers and associations. Additional hybrid LTC insurance products are under development to address evolving customer needs.
AXA Litigation Recovery: If the AXA litigation judgment is upheld, Genworth expects to recover approximately $750 million, with proceeds to be deployed in line with existing priorities, including investments in CareScout, shareholder returns, and debt reduction.
Macroeconomic Positioning: Genworth is positioned to navigate uncertain market conditions in 2026, supported by disciplined underwriting, strong cash flows, and integration of AI technologies to enhance efficiencies and scalability.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Program: Genworth has been actively executing its share repurchase program. Since the initial authorization of the current buyback program, the company has repurchased a total of $875 million worth of shares at an average price of $6.38 as of April 30, 2026. In the first quarter of 2026, $66 million worth of shares were repurchased at an average price of $8.61 per share, with an additional $19 million repurchased through April 30. For the full year 2026, Genworth expects to allocate between $195 million and $225 million to share repurchases, depending on market conditions, business performance, holding company cash, and share price.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the RBC ratio target for GLIC, and are there any plans for capital contributions to life entities?
A:The target RBC ratio for GLIC is 250% or more. Management is comfortable with the current level, which is almost 3x the required capital by regulators. There are no plans for capital contributions to life entities.
Q:What factors impacted the RBC ratio in the first quarter, and what is the outlook?
A:The RBC ratio was impacted by statutory loss, increased mortality, and life pressure from the post-level term block and reserve build. The ratio stood at 289%, which is still considered good. Management does not expect these pressures to continue and plans to execute strategies like the multiyear rate action plan, benefit solutions, and CareScout Quality Network to drive RBC and statutory results.
Q:Can you provide more details on the private credit portfolio, including characteristics, ratings, and sourcing methods?
A:The private credit portfolio includes about 1% in middle market loans accessed through an experienced external manager. The direct lending portfolio has no exposure to the software category. Other private investments include investment-grade private placements, private asset-based finance (average rating of A or BBB), and private equity accessed through experienced advisers like Neuberger and JPMorgan. The portfolio is almost exclusively investment grade.
Q:Review of Unclear Management Responses
A:No questions were avoided or lacked clarity in the responses provided by management.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI partner
Action Plan
Appendix
Block result
CQN
Care Assurance
CareScout Quality
CareScout capability
Closed Block
Quality Network
aging
appeal
approach
approval reduction
brand
care community
care planning
decision
demand
discipline term
efficiency
experience capital
focus
hearing
income Closed
insurance carrier
journey
marketplace
model
opportunity CareScout
position cash
provider care
revenue
shareholder value
stage
stream
sustainability Closed
technology
term opportunity
term value
value term
GNW Transcript
Genworth Financial, Inc. (GNW) Q1 2026 Earnings Call Transcript
Unknown5-6
The earnings call presented a mixed picture: strong share repurchase activity and solid Enact performance are positives, but future premium approvals and Closed Block losses present risks. The Q&A highlighted management's confidence in RBC ratio management and strategic plans to counteract pressures. However, the lack of explicit reasons for financial changes and the uncertainty around future premium approvals and Closed Block sustainability temper overall sentiment. Given the company's market cap and mixed signals, a neutral stock price movement is expected.
Genworth Financial, Inc. (GNW) Q4 2025 Earnings Call Transcript
Positive2-24
The earnings call reveals strong financial performance from Enact, a significant share repurchase program, and optimistic guidance for CareScout's expansion. Despite some risks, such as scaling challenges and regulatory hurdles, the company's strategic investments and capital returns are well-received. The Q&A section highlights management's confidence in CareScout's dual approach, further boosting sentiment. Given the company's market cap, these positive aspects are likely to result in a stock price increase of 2% to 8% over the next two weeks.
Genworth Financial, Inc. (GNW) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call reveals mixed signals. Financial performance shows strong net income and liquidity, but losses in the LTC segment and unclear long-term strategies raise concerns. The Q&A highlights management's vague responses, especially on statutory income and LTC resolution, which may worry investors. The share repurchase plan and potential AXA litigation proceeds are positives, but the lack of clear guidance tempers optimism. Given the market cap, the stock is likely to remain stable, resulting in a neutral sentiment.
Genworth Financial, Inc. (GNW) Q2 2025 Earnings Call Transcript
Unknown7-31
The earnings call summary presents a mixed picture: strong shareholder returns and a promising new product development, but also significant losses in LTC and corporate sectors. The Q&A section reveals management's confidence but also highlights uncertainties, particularly around legal proceedings and the appeal process. The company's strategic focus on share buybacks is positive, but the absence of dividends and unclear management responses to some questions add to the uncertainty. Considering the market cap, the overall sentiment is neutral, with no major catalysts to drive significant stock price movement.
GNW Slides
GNW Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
